Straumann Group Reports Strong 2024 Performance Amidst Global Challenges

Straumann Group reported a 13.7% organic revenue increase in 2024, reaching CHF 2.5 billion. The fourth quarter saw an 11.5% growth, with revenue hitting CHF 645 million. The Group's strategic focus on innovation and execution drove success, highlighted by the global introduction of the iEXCEL implant system.

Regionally, Asia Pacific led with 18.9% growth, bolstered by demand in China. The EMEA region showed resilience, achieving 12.3% growth, while North America saw stabilization in Q4. Latin America maintained double-digit growth.

Despite currency headwinds, the core EBIT margin stood at 26%, rising to 27.6% at constant rates. The Group also invested in digital transformation and workforce development. The Board proposed a dividend increase to CHF 0.95, looking ahead to a positive 2025 with continued investment plans.